> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-146/
- Published: 2017-08-27T12:00:00.000Z
- Updated: 2026-09-14T22:43:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139484

[**Draft Guide on Drug Supply Trading Partners**](https://www.fdaweb.com/draft-guide-on-drug-supply-trading-partners/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Identifying Trading Partners Under the Drug Supply Chain Security Act.” 08/25/2017

[**Guidance on Oncology Drugs for Companion Animals**](https://www.fdaweb.com/guidance-on-oncology-drugs-for-companion-animals-2/)  
*Federal Register* notice: FDA makes available a guidance for industry #237 entitled “Oncology Drugs for Companion Animals.” 08/25/2017

[**Comments Sought on eSubmissions for CDRH Product Complaints**](https://www.fdaweb.com/comments-sought-on-esubmissions-for-cdrh-product-complaints/)  
*Federal Register* notice: FDA seeks comments on an information collection entitled “Electronic Submission Process for Voluntary Allegations to the Center for Devices and Radiological Health — OMB Control Number 0910–0769.” 08/24/2017

[**Comments Sought on OTC Drugs Under GRASE**](https://www.fdaweb.com/comments-sought-on-otc-drugs-under-grase/)  
*Federal Register* notice: FDA seeks comments on an information collection related to “Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded — 21 CFR 330.14.” 08/23/2017

[**Advisory Committee to Review PTC Therapeutics NDA**](https://www.fdaweb.com/advisory-committee-to-review-ptc-therapeutics-nda/)  
*Federal Register* notice: FDA announces a 9/28 Peripheral and Central Nervous System Drugs Advisory Committee meeting to review a PTC Therapeutics NDA for ataluren. 08/23/2017

[**Comments Sought on Informed Consent Exception for Diagnostics**](https://www.fdaweb.com/comments-sought-on-informed-consent-exception-for-diagnostics/)  
*Federal Register* notice: FDA is seeking comments on an information collection extension for “Medical Devices; Exception From General Requirements for Informed Consent.” 08/22/2017

[**Pediatric Advisory Committee to Conduct Safety Reviews**](https://www.fdaweb.com/pediatric-advisory-committee-to-conduct-safety-reviews/)  
*Federal Register* notice: FDA announces a 9/11-12 Pediatric Advisory Committee meeting in Rockville, MD to conduct pediatric-focused safety reviews. 08/22/2017

[**Docket Established for DTC Risk Info Recommendations**](https://www.fdaweb.com/docket-established-for-dtc-risk-info-recommendations/)  
*Federal Register* notice: FDA establishes a public docket to assist with its development of recommendations on the communication of risk information in direct-to-consumer broadcast ads. 08/22/2017

[**CDRH Mailing Address Change for Device Classifications**](https://www.fdaweb.com/cdrh-mailing-address-change-for-device-classifications/)  
*Federal Register* final rule technical amendment: FDA is amending the Medical Device Classification Procedures regulation to reflect a change in address for CDRH. 08/22/2017